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Abstract
The expression microarray is a frequently used approach to study gene expression on a genome-wide scale. However, the
data produced by the thousands of microarray studies published annually are confounded by ‘‘batch effects,’’ the
systematic error introduced when samples are processed in multiple batches. Although batch effects can be reduced by
careful experimental design, they cannot be eliminated unless the whole study is done in a single batch. A number of
programs are now available to adjust microarray data for batch effects prior to analysis. We systematically evaluated six of
these programs using multiple measures of precision, accuracy and overall performance. ComBat, an Empirical Bayes
method, outperformed the other five programs by most metrics. We also showed that it is essential to standardize
expression data at the probe level when testing for correlation of expression profiles, due to a sizeable probe effect in
microarray data that can inflate the correlation among replicates and unrelated samples.
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Introduction
Gene expression microarray technology [1,2,3,4] measures the
expression of thousands of genes in a single assay, using multiple
probes to assay each transcript. It is a revolutionary tool for
identifying genes or pathways whose expression changes in response
to specific perturbations. Promising as it is, there are concerns
regarding the reliability, and hence the utility, of DNA microarray
technology in the study of physiological processesand diseases [5,6].
Gene expression microarray results can be affected by
minuscule differences in any number of non-biological vari-
ables[7], so reagents from different lots, different technicians or
even changing atmospheric ozone levels[8] can impact the data.
Here, the term ‘‘batch’’ refers to microarrays processed at one site
over a short period of time using the same platform. The
cumulative error introduced by these time and place-dependent
experimental variations is referred to as ‘‘batch effects."
Batch effects are almost inevitable; largely because most of the
available microarray platforms can assay fewer than 24 samples at
a time (the latest technology may process 96 samples in each
batch). Since hundreds or thousands of samples may be needed for
population studies, samples for high-throughput microarray
studies must often be processed at different times and/or sites.
However, of the thousands of DNA microarray papers published
every year, few address the problem. Of the 219 papers using
microarray data published from January 1 to July 1, 2010, less
than ten percent addressed this issue (NCBI GEO database,
studies with more than 30 samples)[9].
A number of approaches have been used or developed for
identifying and removing batch effects from microarray data[10],
of which we have chosen six for evaluation. Distance-weighted
discrimination (DWD)[11], based on the Support Vector Ma-
chines (SVM) algorithm, is a two-class discrimination analysis
for high-dimension low sample size data. Mean-centering
(PAMR)[12] is a gene-wise one-way analysis of variance
(ANOVA). Surrogate variable analysis (SVA)[13], combines
singular value decomposition (SVD) and a linear model analysis
to estimate the eigenvalues from a residual expression matrix from
which biological variation has already been removed. Geometric
ratio-based method (Ratio_G) scales sample measurements by the
geometric mean of a group of reference measurements [14]. An
Empirical Bayes method, called Combating Batch Effects When
Combining Batches of Gene Expression Microarray Data
(ComBat)[15], estimates parameters for location and scale
adjustment of each batch for each gene independently[16];
ComBat includes two methods, a parametric prior method
(ComBat_p) and a non-parametric method (ComBat_n), based
on the prior distributions of the estimated parameters. We
excluded the following algorithms either because they have
already been shown by previous studies to be inferior to one or
more of the methods we are analyzing, or because they are minor
variations of those methods[13,14,15]: singular value decomposi-
tion (SVD)[17], standardization (Location/Scale adjustment
model)[16], a ratio-based method with arithmetic mean (Ra-
tio_A)[14]. Sources for the programs we evaluated, plus some of
their computational features, are provided in Table S1.
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comparable results; however, since they are based on different
statistical models, their accuracy, precision and overall effective-
ness vary. In this paper, we sought to identify the algorithm that
removes batch effects most effectively, including striking the
optimal balance between precision and accuracy. Simulated data
were used for each initial assessment, so the true values would be
known a priori, and experimental data were used for verification.
We created two simulation data sets. The first was the Variation
Assessment Simulated (VAS) data set, comprising 100 samples, 65
of which were assigned to Profile 1 and 35 of which were assigned
to Profile 2, where profile was a generic random variable.
Expression values for 991genes were simulated, all of them
differentially expressed between the two profiles. This data set was
generated twice, with different levels of batch effects incorporated
each time, creating technical duplicates for comparison. The
second simulated set, the Accuracy Assessment Simulated (AAS)
data, consisted of 100 cases and 100 controls, with 1,200 out of
10,000 genes being differentially expressed with 12 different fold
change values ranging from 23 to 3. The data incorporated a
range of batch sizes and variable amounts of batch effects.
Both experimental brain expression data sets were produced
using the Affymetrix GeneChip Human Genome U133A Array, a
short oligonucleotide cDNA microarray. The Stanley Medical
Research Institute (SMRI) data set included three technical
replicates of 62 individuals, with each replicate processed in one
of three laboratories [18] Based on place and date of processing,
the samples were run in 23 batches, averaging eight samples with
at least one case and one control per batch. The Affymetrix
U133A spike-in set (http://www.affymetrix.com/support/
technical/sample_data/datasets.affx), comprised three technical
replicates of 14 separate hybridizations of 42 spiked transcripts at
concentrations ranging from 512 pM down to 0.125 pM. Like the
simulation data, true positives and true negatives were known for
this data set.
The VAS and SMRI data were used for variation and precision
assessment; the AAS and spike-in data were used for accuracy and
overall performance evaluation. All the batch adjustment methods
were applied after experimental data were pre-processed by robust
multiarray analysis (RMA)[19], which summarizes the probe level
expression data into a probe set level expression value; a probe set
consists of 11 to 20 probes used to assay the expression of one gene
or exon. The simulated data sets were defined as the probe set
level expression values that would be obtained from RMA
processing.
We first measured how much each program reduces the
variation caused by batch effects. In the VAS data set, the
variation came only from batch and Profile effects. To verify our
simulation result, we used SMRI data, in which nine factors are
considered possible sources of variation and batch effects were
divided into site and date effects separately. In both the simulated
data and experimental data, variation attributable to batch effects
before and after batch adjustment were identified using principal
variation component analysis (PVCA)[10,20].
To test the programs’ precision, we assessed whether the
expression values of the technical replicates correlated better
before or after batch adjustment, first between the two replicates
from the VAS data using Pearson’s correlation coefficient, then
among the three SMRI replicates as assessed by intraclass
correlation (ICC).
As a measure of accuracy, the programs’ abilities to accurately
quantify fold change in expression were assessed using the
correlation between nominal fold changes and observed fold
changes. The signal detection slope [21], i.e., the slope of the line
produced by regressing the nominal fold change against the
observed fold change, was also calculated. The Affymetrix spike-in
dataset was used to verify the result.
To assess the overall detection ability of each program, we used
a receiver operator characteristic (ROC) curve. ROC curves plot
the true positive rate (i.e., sensitivity) against the false positive rate
(i.e., 1-specificity). The actual test statistic is the area under the
curve (AUC); the program with the optimal combination of
sensitivity and specificity will have the largest area of AUC. The
ROC-AUC of the AAS data was calculated, and then the
Affymetrix spike-in data was used to validate the simulation result.
We also tested each program’s ROC-AUC result with variously
sized batches in the AAS data.
Our ultimate goal was to identify the batch adjustment method
that best prepares data from multiple batches for analysis or meta-
analysis to be integrated, as measured by batch effects reduction,
accuracy, precision and overall performance.
Results
Proportion of variation attributable to batch effects
We used principal variation component analysis (PVCA)[10,20]
to measure how much variation in the expression data was
attributable to batch effects. PVCA estimates source and
proportion of variation in two steps, principal component analysis
(PCA) and variance component analysis (VCA). The principal
components (PCs) identified in the PCA that together account for
a predetermined proportion of variation, here 60%, are retained
for the VCA. The VCA uses a linear model to match each PC to a
known source of variation, in this case batch effects, profile effects
and interaction between batch and profile effects. The variation in
each PC is weighted by its eigenvalue from PCA, and the resulting
value represents the overall variation explained by that compo-
nent.
The PVCA revealed that batch effects explained 30.4% of the
overall variation in the VAS RMA data (Figure 1A). All batch
adjustment methods reduced that variation to some degree, and
three, ComBat_p, ComBat_n and PAMR, eliminated it com-
pletely (Figure 1B). Interaction between batch and profile
explained 22.1% of the variation in the RMA data, which was
reduced to less than 5% by all batch adjustment methods and to
less than 1% by ComBat_p, ComBat_n, PAMR and SVA. This
reduction made the biological variation due to profile more
apparent, increasing it from 0.014 (RMA) to 0.171(ComBat_p),
0.170 (ComBat_n), 0.398 (PAMR), 0.250 (DWD), 0.391 (SVA)
and 0.256 (Ratio_G) after the removal of batch effects.
We obtained similar results from the experimental SMRI data
set (Figure 2). This time, we considered nine possible sources of
variation, as provided by SMRI: date effects, site effects, disease
profile, brain pH, post-mortem interval (PMI), age, suicide status,
smoking status at time of death and presence of psychotic features.
The first seven PCs met our 60% threshold of variation. In the
unadjusted data, PVCA showed that batch effects were responsible
for almost half of the overall variation detected by the first seven
PCs, including 42% attributable to site effects and 7% to date
effects (Figure 2A). The next largest effect came from PMI,
which accounted for only 9% of the variation.
After applying ComBat_p or ComBat_n, only 1% of the total
variation was still attributable to batch effects: this represents a
98% reduction in batch effects and a 48% reduction in total
variation. PAMR was almost as effective, reducing batch effects by
98%. SVA, DWD and Ratio_G were less so, at 94%, 73% and
57%, respectively.
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Precision refers to the closeness of the set of values obtained
from multiple testing of identical samples. The precision of
expression measures can be assessed by testing correlation among
replicates, which we did between the VAS duplicates using
Pearson’s correlation coefficient and among the 62 SMRI
triplicates using intraclass correlation coefficient (ICC) [22]; ICC
is appropriate for assessing correlation among groups, while
Pearson’s is intended to measure correlation between pairs.
First, however, due to the sizeable probe effect in microarray
data, which can inflate the correlations between sample pairs
regardless of whether the sample pairs are replicates[23], we
standardized each probe set value to a mean expression value of 0
and a standard deviation (s.d.) of 1. Prior to standardization, the
Figure 1. PVCA results in VAS data. The contribution of each factor to the overall variation was estimated by PVCA. All the effects, including
batch effects, Profile effects, interaction between batch and Profile effects, and residuals, were estimated for their contribution to the overall
variation. A. Data without batch adjustment. B. Data processed by ComBat_p as batch adjustment tool/model. C. Data processed by ComBat_n. D.
Data processed by PAMR. E. Data processed by DWD. F. Data processed by Ratio_G. G. Data processed by SVA.
doi:10.1371/journal.pone.0017238.g001
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were all .0.9; afterwards, the median correlation among non-
replicates was zero (Figure S1).
After this standardization, we calculated Pearson’s correlation
coefficient of the replicates in VAS data, before and after batch
adjustment. To compare the difference of the correlation
coefficients, we transformed the correlation r to approximately
normally distributed z-scores (Figure S2). All batch removal
methods increased the replicates’ correlation: the improvements of
the probes’ correlation distribution were all significant with
p,0.0001. ComBat and DWD showed the largest median
differences (Table S3, Row 6).
In the SMRI experimental data, ICC was calculated for each
probe set among the three replicate groups. The median z-score of
Figure 2. PVCA results in SMRI data. The contribution of each factor to the overall variation was estimated by PVCA, A. Data without batch
adjustment. B. Data preprocessed by RMA with ComBat_n as batch adjustment tool/model. C. Data preprocessed by RMA with ComBat_p. D. Data
preprocessed by RMA with PAMR. E. Data preprocessed by RMA with DWD. F. Data preprocessed by RMA with Ratio_G. G. Data preprocessed by RMA
with SVA.
doi:10.1371/journal.pone.0017238.g002
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were 0.305 for ComBat_p, 0.304 for ComBat_n, 0.298 for PAMR,
0.319 for DWD and 0.268 for Ratio_G. The increases in median
ICC z-scores were all significant (p-values,0.0001). The differ-
ences among ComBat_n, ComBat_p, PAMR and DWD were not
significant, but they were all significantly better than Ratio_G
(p,0.0001). Only SVA failed to increase the median z-score
significantly (0.209, p=0.407) (Figure 3; Table S3, Row 7).
Accuracy
Accuracy refers to the closeness of a single measurement to its
true value. We assessed accuracy by calculated how much each
program increased the correlation between nominal fold changes
and the observed fold changes in the AAS data after the fold
changes were transformed to log 2 scale. Except for SVA
(Spearman’s correlation, r
2=0.95), all programs increased the
correlation between nominal log 2 fold change value and observed
fold change value (p,0.0001), ComBat_p (r
2=0.98), ComBat_n
(r
2=0.98), PAMR (r
2=0.97), DWD (r
2=0.97), Ratio_G
(r
2=0.96), compared to the unadjusted RMA result (r
2=0.95)
(Figure 4). Although small, the differences in correlation
coefficient between ComBat (both ComBat_n and ComBat_p)
and the next best program, DWD, were also significant
(p,0.0001).
We also calculated each program’s signal detection slope[21], which
is the slope of the line produced by regressing nominal fold change
against observed fold change; a slope of 1 indicates that nominal
fold changes and observed fold changes are identical. The signal
detection slope of the 1,200 nominally differentially-expressed
genes in our unadjusted simulated data set was 1.01. There was no
room for improvement, and none of the methods improve upon
the RMA result; SVA, Ratio_G and DWD actually significantly
decreased the accuracy, with Ratio_G decidedly the worst with the
significantly lower slope of 0.90 (p,0.0001) (Table S3, Row 10).
To verify these results, we measured each program’s correlation
and slope in the Affymetrix experimental spike-in data set. SVA
had the worst correlation again (r‘2=0.56 vs. r‘2=0.90, RMA
data, p,0.0001), and decreased the slope from 0.68 to 0.51
(p,0.0001) (Figure S3).
Overall performance
We used ROC curves to determine which program best
optimized both sensitivity and specificity, i.e., maximized true
positives (TP) while minimizing false positives (FP). To create an
ROC curve, TP rate is plotted against FP rate; the actual test
statistic is the area under the curve (AUC) [24] (Figure 5). The
larger AUC, the better the program’s performance. The AUC for
the unadjusted data was 0.854. ComBat_p and ComBat_n
increased the AUC (0.937, p=4.51e230, p=1.42e229, respec-
tively), followed by DWD (0.917, p=5.88e215), PAMR (0.913,
p=2.25e213), and Ratio_G (0.895, p=1.20e206). SVA did not
increase the AUC significantly (0.858, p=0.27) (Table S3, Row
15). The results were similar in the Affymetrix spike-in data,
except that SVA actually decreased the AUC value, from 0.93 to
0.76 (p,0.0001) (Figure S4).
To compare the methods’ performances over a range of batch
sizes, we re-set batch sizes at 20, 40 and 100 samples, re-generated
the AAS data and recalculated the AUCs. The difference in AUC
between ComBat and the other methods increased as the batch
size decreased, suggesting that this Empirical Bayes approach is
particularly appropriate for studies with fewer samples per batch
(Figure S5).
Discussion
In order to achieve adequate statistical power for population-
based studies, sample sizes are considerably larger than the
capacity of an individual microarray. Samples are unavoidably run
in multiple batches due to technical and time constraints, making
batch effects a source of non-biological variation that can increase
error [25,26]. When microarray technology was new, some
researchers held that a well-designed experiment, using the same
technician, lab and platform, could eliminate batch effects
completely; as a result, many published reports of microarray
data ignored batch effects in their analyses and even in their
discussions. However, we now know that the causes of batch
effects include variables simply not under the control of the
researcher. Batch effects have been definitively demonstrated in
microarray studies[7,27], hence the development of algorithms
designed to reduce them. In the SMRI brain expression
microarray data set, batch effects accounted for nearly 50% of
the observed variation in expression, to which site effects
contributed 42% and date effects 7.3%.
We compared six methods for reducing or completely removing
batch effects, using experimental and simulated microarray
expression data. Although each method was effective according
to one or more measures, ComBat outperformed other methods
overall. Its parametric and non-parametric algorithms both
worked well in both kinds of data sets, controlling the variation
attributable to batch effects, increasing the correlation among
replicates, and producing the largest AUC in our assessment of
overall performance. We also confirmed another advantage of
ComBat: it can robustly manage high-dimensional data when
sample sizes are small, which is important for experiments with
limited sample size, meta-analyses and clinical diagnostics.
Moreover, ComBat not only worked well on data generated on
Figure 3. Distribution of SMRI ICCs after transformation.
Boxplots of the distribution of z-scores transformed from intraclass
correlation coefficients of probe set expression levels between three
SMRI technical replicates. The methods are listed along the X axis. The Y
axis is the distributions of all probe sets’ ICC z-scores. The top of the box
represents the top of the third quartile, the bottom of the box
represents the bottom of the first quartile, the middle bar is the median
value, box whiskers extend to 1.5 times the interquartile range from the
box and circles are possible outliers. Dmedian indicates the median
difference of z-score distributions between RMA data and data that has
been processed with both RMA and the batch-adjustment method.
Except for SVA, all batch adjustment methods significantly increased z-
scores (p,0.0001).
doi:10.1371/journal.pone.0017238.g003
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with Illumina BeadChips data [28].
The other commonly-used methods we evaluated were PAMR,
DWD, Ratio_G and SVA. DWD did not perform well in our
analyses when batch sizes were small. In addition, it can only
analyze two batches at a time. Three or more batches may still be
adjusted with DWD, using a stepwise approach[11], but this
would not be convenient for large studies. Moreover, the
standardization or normalization in DWD can change the scale
between cases and controls, which is why the correlation between
nominal and observed fold change was high after DWD
processing, but the signal detection slope was very low. An
addition re-scaling step would be required to allow results from
different studies to be compared. SVA is based on SVD. It is
effective, but has several limitations. First, it is not necessarily a
simple matter to identify the batch effect eigenvector. Batch effects
may actually contribute substantially to several of the top
eigenvectors, so SVD may not identify and remove all the batch
effects, and may remove other effects not related to batch. Second,
a basic assumption of SVD is that the eigenvectors have Gaussian
distributions. Batch effects, however, may be due to changes in
technician, reagents, environmental conditions, scanner effects
Figure 4. Correlation between the nominal fold changes and observed fold changes in AAS data. Correlation between the nominal fold
changes and observed fold changes in RMA data and data after batch adjustment programs. We simulated 1200 genes out of 10000 genes as
differentially expressed, with log 2 fold change range 21.58, 21.32, 21, 20.58, 20.26, 20.14 and 0.14, 0.26, 0.58, 1, 1.32, 1.58, responding to fold
changes that range 23, 22.5, 22, 21.5, 21.2, 21.1 and 1.1,1.2,1.5,2,2.5,3 to reflect the approximate number of differentially expressed genes in the
real data. The regression slopes were shown in colors by different program. Correlation coefficients (r
2) were shown in legend, separately.
doi:10.1371/journal.pone.0017238.g004
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batch effects not being distributed in a Gaussian manner. Finally,
SVD is not robust to outliers when compared with an Empirical
Bayes method.
Ratio_G scales values by the geometric mean of a group of
controls or reference samples, while PAMR shifts values by
batches’ arithmetic mean. Luo and colleagues [14] demonstrated
that Ratio_G outperforms other methods in adjusting data for use
in a predictive model, and reasoned that it is because non-ratio-
based methods can confound batch and biological effects when
one batch has a reverse negative/positive ratio compared to
another batch. To test this, in our AAS data design, we simulated
batches with very different case/control ratios, i.e., 10 cases and 30
controls in one batch and 30 cases and 10 controls in another.
However, accuracy and ROC-AUC results indicated that
Ratio_G performed worse than ComBat_p and ComBat_n. Also,
Ratio_G performed worst in removing batch effects from the
SMRI data.
PAMR sets the mean of each probe set within a given batch to
zero. It did very well in our measures of accuracy because of this
simple transformation. Again, though, batch effects are compli-
cated, and do not affect all samples equally. PAMR does treat all
samples equally, so it can over- or under-correct particular samples
and came in second to ComBat in our measures of precision.
ComBat treats batch effects as additive and multiplicative
effects. So it is basically a mixture of a mean-centering algorithm
like PAMR, and a scale-based algorithm similar to Ratio G. This
dual approach probably explains ComBat’s superior overall
performance.
Note, however, that even the most effective batch effect removal
program cannot correct for poor experimental design. If cases and
controls are run in separate batches, genuine biological variation
can be entirely confounded by batch effects. Indeed, this is what
we found when we re-configured our simulation data to run cases
and controls separately, and re-analyzed it. No method was able to
reduce the batch effects sufficiently without also removing the
variation caused by case-control differences (Table S2).
A previous attempt to assess the extent of batch effects and the
effectiveness of batch adjustment methods was made by the
MAQC-II project [29]. This project’s primary goal was to use
existing data to create a model to predict class labels for future
samples, where the classes, or endpoints, included treatment
response, overall survival or likelihood of a specific disease. This
predictive model is designed for use in both clinical settings and in
research seeking to develop new gene expression signatures and
biomarkers. Luo and colleagues investigated the effect of batch
effect removal on the performance of this predictive model[14], as
measured by Matthew Correlation Coefficient (MCC), using five
different removal methods on six batches of MAQC microarray
data, where sources of batch variation included different
hybridization dates, different generations of chips, different
channels, different platforms and different tissues.
They tested mean-centering, ratio-based, standardization and
Empirical Bayes methods, and found them all to perform better than
no batch adjustment 75% to 89% of the time, with the geometric
ratio-based (Ratio_G) method performing the best. DWD and SVD/
SVA were not evaluated, because Luo and colleagues wanted to
develop their predictive model based on the existing data, referred to
as the training data, which would not be affected when the model was
applied to future samples. They used MCC because it is informative
with very different class sizes, straightforward to calculate, and
applicable for all 30,000+ of their models.
We, on the other hand, assessed how batch adjustment methods
improve the integration of data processed at different sites or times
when used as a standard quality control step post-RMA and pre-
integration. This meant not only that we had a different aim than
Luoand colleagues, butthat we had fewerconstraints. Forexample,
we were able to assess widely-used algorithms, such as DWD and
SVD/SVA, which they did not since would alter the training data.
Also, although when we calculated MCC for our data (Table S3,
Row 9) the results mirrored our accuracy and ROC-AUC results,
the precision results elucidated differences among the programs not
revealed by MCC, our accuracy measures or the ROC curves. For
example, by testing multiple aspects of performance, rather than
relying on a single measure, we demonstrated that while SVA
substantially reduced the proportion of variation attributable to
batch effects, as well performing with precision,itactuallydecreased
accuracy relative to the unadjusted data. We also showed that
PAMR performed very accurately, but slightly less precisely. We
performed each test on both simulation data and experimental data;
the simulation data let us control the variables and know the true
values a priori, and then we were able to validate the simulation
results in real data. Because we were not creating a prediction
model, which is a combination analysis with batch correction,
feature selection, classification and model selection, we were able to
assess data before and after batch adjustment directly: this
eliminates the potential for variation being introduced by those
additionalprocedures.Finally,we tookonly date and site effectsinto
consideration, since platform-, channel- or tissue-dependent
variations are avoidable with careful experimental design.
These differences in research design can explain why Luo and
colleagues rated Ratio_G the highest, while we found ComBat to
be superior. For example, Ratio G performed particularly well
only in one MAQC data set, a data set for which the stated source
of batch effect was cross-tissue. However, cross-tissue effects would
be expected to be due to biological variation between tissues as
well as technical variation, presumably related to tissue collection
and extraction. So, it is not clear whether all the variation removed
was technical or whether all the technical variation was removed.
Moreover, in the predicted model summary, this data set was used
in 32 of 120 models, while other data sets were only used in 8 or 16
Figure 5. ROC curves in AAS data. ROC curves are graphical
representations of both specificity and sensitivity that take into account
both differentially and non-differentially expressed genes. ComBat_p
and ComBat_n performed almost identically, so their curves overlap
each other almost completely.
doi:10.1371/journal.pone.0017238.g005
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analysis. If we examine separately the MAQC-II data sets in which
hybridization date is the only source of batch effects, ComBat
appears to increase MCC at least as well as Ratio_G does [14].
Wedetectedastrongprobeleveleffectafterapplying RMAtothe
SMRI data and finding that the probe set expression values among
replicates correlated no better than among non-replicates. We
observed that the array level variation (ch) was well-controlled, but
theprobe setlevel variation(cQ) was notalleviated byRMA(Figure
S6), which is consistent with a previous study[23]. As the correlation
between each individual array is ch
 
(chzcQzce) where ce
represents the variation of measurement error, a high cQ will result
in an artificially high correlation between different arrays. To solve
this,westandardizedthe probesetvariationbystandardizingmeans
and variances across replicate groups, which keeps the variability
between pairs but lowers the overall variation. After standardiza-
tion, correlation among non-replicates fell to zero (Figure S1).
Our evaluation makes clear that adjustment for batch effects is a
mandatory step in the analysis of microarray data when the sample
size is too large to fit in a single batch. Of the batch adjustment
methods we evaluated, we found that the empirical Bayes algorithm
implemented in ComBat was best able to reduce and remove batch
effects while increasing precision and accuracy. It outperformed the
secondbest programbyasubstantialmarginonmanymeasuresand
by a small but significant margin on others. Unlike the other
programs, each of which had at least one major drawback, ComBat
performed satisfactorily on all measures. PAMR was a close second,
but its performance suffered when batch size was small; only
ComBat performed robustly when adjusting small batches. Finally,
we recommend that probe set expression values always be
standardized prior to assessing correlation among replicates, to
avoid misleadingly high correlations.
Materials and Methods
Samples
T h eS M R Ib r a i ns a m p l e sc a m ef r o mt w ob r a i nc o l l e c t i o n s ,t h e
SMRI Array collection and the SMRI Consortium collection[18].
The SMRI Array collection includes 70 patients and 35 controls.The
Brodmann area 46 of each sample was assayed in three groups using
the Affymetrix GeneChip Human Genome U133A platform. The
three studies had 62 samples in common after outliers were removed
using Expression Console[30], which we used as our technical
replicates. The 7643 probes that were coded as present callin 80% or
more of the samples were included in our analyses[31].
Expression microarray data simulations
We generated two simulated expression microarray data sets. In
the variation assessment simulated (VAS) data, we generated 100
samples for which 1000 probes were measured. Samples were
assigned to one of two undefined profiles, which could represent
disease status, drug treatment or similar random variable, 65 to
Profile 1 and 35 to Profile 2. The simulation was run twice: the
first replicate group was generated as if run in a single batch, while
the second replicate group generated as if run in two batches. To
address batch effects and treatment effect, we assumed the data
followed an L/S model,
Yijg~agzXbgzcigzdigeijg (1),
Where ag represents the overall gene expression, X is a design
matrix for profile conditions, and bg is the vector of regression
coefficients corresponding to X. The additive and multiplicative
batch effects of batch i for gene g are represented by cig and dig,
respectively. Measurement error is represented by eijg, and is
normally distributed, with an expected value of zero and
variance s2
g.
Parameters ag and bg were set such that probe sets were
differentially expressed between the two profiles. Across Profile 1,
probe sets’ average expression intensities followed a normal
distribution, and across Profile 2, probe sets’ expression intensities
have a variety of fold changes relative to Profile 1, ranging from
23 to 3. Standard deviation of gene g was set to ensure that the
gene was genuinely differently expressed, rather than highly
variable: Sgv
X1g{X2g
1:96
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
n1 z 1
n2
q , where X1g is the mean intensity of
gene g and n1 is the sample size of Profile 1, and X2g is the mean
intensity and n2 is the sample size of Profile 2. After significance
testing and multiple test correction, we were left with 991
differentially expressed probe sets with various fold changes for
further analysis. Batch scale parameters, cig, dig, were added to
reflect a typical range of observed values, which followed normal
distribution and inverse-gamma distribution, respectively. All the
distribution and fold change parameters were set to reflect those of
the biological data.
The second simulated data set was the accuracy assessment
simulated (AAS) data, which included probe set expression values
for 10,000 probe sets in 100 controls and 100 patients. We again
followed Equation (1), where X is a design matrix for sample
conditions. Parameters ag and bg were set such that 1200 of the
10,000 genes had mean fold changes ranging from 23t o3i n
cases relative to controls. Approximate standard deviation was set
so that some lower fold change genes were differentially expressed,
so we could test whether small fold changes were still detectable
after batch correction.
Measuring source of variation
The PVCA approach (http://www.niehs.nih.gov/research/
resources/software/pvca/index.cfm) was used to estimate sources
of variability and compare batch effects before and after
adjustment in the VAS and SMRI microarray data sets. We first
selected the top PCs, enough to explain a proportion of overall
variation larger than a pre-defined threshold (60%–90%, 60% in
this case), and retained the corresponding eigenvalues. Each factor
was treated as random in a mixed linear model and matched to a
PC, then weighted by that PC’s corresponding eigenvector. After
we standardized the variation attributable to each factor, we
calculated the proportion of total variance each factor explained.
Including residuals, four factors’ variations were estimated in the
VAS data and ten factors’ variations were estimated in SMRI
data.
Signal detection slopes were calculated using the spkTools[21]
R package. The significances of differences between slopes were
assessed with a test for homogeneity of slope[32], which was done
with the NCStats R package[33]. The evaluation of overall
performance was performed using the ROCR[34] R package from
Bioconductor[35].
Supporting Information
Figure S1 Correlation before and after standardization.
Compare the replicate samples correlation between pre-standard-
ization and post-standardization. Data was downloaded from
Affymetrix U133A sample data including three replicates for 12
different tissues. Affy12, affy23, affy13 are replicates’ correlation
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PLoS ONE | www.plosone.org 8 February 2011 | Volume 6 | Issue 2 | e17238groups between replicate group 1 and replicate group 2, replicate
group 2 and replicate group 3, replicate group 1 and replicate
group 3, respectively. AffyN12, affyN23, affyN13 are non-
replicates’ correlation between group 1 and 2, group 2 and 3,
group 1 and 3, respectively. http://www.affymetrix.com/support/
technical/sample_data/gene_1_0_array_data.affx.
(TIF)
Figure S2 Distribution of z scores in VAS data. Box plots
of the distribution of z scores transformed from Pearson
correlation coefficients between simulated replicates. The methods
are listed along the X axis. The Y axis is the distributions of all
probes’ z scores. The top of the box represents top of the third
quartile, the bottom of the box represents the bottom of the first
quartile, the middle bar is the median value, box whiskers extend
to 1.5 times the interquartile range from the box and circles are
possible outliers. The differences of correlation distribution are all
significant with p value less than 0.0001; differences of
distribution’s median between RAW data and data have been
processed with batch-adjustment methods are listed below the box
plots.
(TIF)
Figure S3 Slope test in Affymetrix spike-in data.
Observed versus nominal values in Affymetrix Latin square design
spike in data, for RMA data and post batch adjustment methods.
Expression values are plotted against the log (base 2) of the
reported nominal concentration. The regression slope obtained
utilizing all the data and the regression slopes obtain within each
low, medium and high average log expression (ALE) value strata
are shown. The slope of each line is reported in the legend. The
vertical lines divide the ALE strata.
(TIFF)
Figure S4 ROC curves in Affymetrix spike-in data. ROC
curves are graphical representations of both specificity and
sensitivity that take into account both differentially and non-
differentially expressed genes. Concentration pairs with fold-
changes of 2 in spike-in genes were used to determine TP.
Concentration pairs without any fold-changes were used to
determine TN. We selected top 1000 log-ratio pairs to report.
(TIFF)
Figure S5 Compare of the AUCs in AAS data. The
differences of the AUC between ComBat and the next best batch
adjusted method are different when the sample size of each batch
varies. From the left, the differences are 0.03, 0.02 and 0.01, as the
batch sizes increase from 20, 40 to 100.
(TIFF)
Figure S6 Array level and probe set level variation.
Boxplot of the RMA normalized SMRI data for (A) all the 186
arrays and (B) all 7643 probe sets. Y axis is the log2 intensity value
and x axis is the (A) arrays or (B) probe sets. After RMA, gene
intensity distributions are similar between arrays but not probe
sets, leading to artificially large correlations between non-replicate
arrays.
(TIFF)
Table S1 Detailed computational description of six
programs. Detailed computational features of each program
are provided, including software implement, file format, relative
execution time, computational burden, batch size, URL of the
available software and some program-specific notes.
(DOC)
Table S2 Batch effect completely confounded with
outcome variation. We simulated the data with all cases in
one batch and all controls in another. There are 1200 true positive
genes in this dataset. The binary classification table shows
overlapped positives genes among the true condition and with or
without batch adjustment methods: before batch correction, there
were 6518 significant results in raw data, with 62.4% (5495 out of
8800) false positive rate (FPR) and 14.8% (177 out of 1200) false
negative rate (FNR); After batch correction, ComBat_p got 7
positive results with 0% FPR and 99.0% FNR; ComBat_n got 12
positive results with 0.1% FPR and 99.8% FNR; DWD got 402
positive results with 3.2% FPR and 89.9% FNR. None of the true
positives were caught by PAMR and SVA with 0% FPR and
100% FNR. No control samples in the first batch so Ratio_G can’t
be applied for this adjustment.
(DOC)
Table S3 Assessment summary statistics table. The
second column indicates the figure to which the summary statistic
relates. Columns 3 through 9 show values for RMA, ComBat_p,
ComBat_n, PAMR, DWD, SVA and Ratio_G, separately. The
statistics are described in the text and best result is shown in bold.
Abbreviations: PVCA, principal variation component analysis;
ICC, intraclass correlation; ACC, accuracy; MCC, Matthew
Correlation Coefficient; AUC, area under the curve.
(DOC)
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